100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
1263-89-4Neomycin Sulfate EP Impurity E
● In Stock
| Catalogue No.: | VE006931 |
|---|---|
| CAS No.: | 1263-89-4 |
| Mol. Formula: | C23H45N5O14 . H2SO4 |
| Mol. Weight: | 615.63 . 98.07 |
Additional information on CAS 1263-89-4
Parent drug
NeomycinIUPAC Name
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol sulfateSynonyms
Aminosidine SulfateDescription
Also known as Aminosidine Sulfate, it is an impurity present in Neomycin that is bactericidal in vitro against a wide variety of gram-negative and gram-positive organisms, including some that are streptomycin-resistant, and also it is utilized in dermatological therapy.References
Szychowski, Janek, et al. “Inhibition of Aminoglycoside-Deactivating Enzymes APH(3?)-IIIa and AAC(6?)-Ii by Amphiphilic Paromomycin O2??-Ether Analogues.†ChemMedChem, vol. 6, no. 11, Sept. 2011, pp. 1961–66, https://doi.org/10.1002/cmdc.201100346 Kile, Roy L. “USE of NEOMYCIN in DERMATOLOGY.†JAMA: The Journal of the American Medical Association, vol. 148, no. 5, Feb. 1952, p. 339, https://doi.org/10.1001/jama.1952.02930050011003.?Request a Quote
« * » indique les champs nécessaires
Other products related to Neomycin impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
Neomycin Sulfate/ Neomycin
CAS No. 1405-10-3
Cat No. VE0028486
Neomycin/ Framycetin / Paromomycin
CAS No. 51795-47-2
Cat No. VE006932
